A Coronavirus Disease 2019 (COVID-19) Mystery: Persistent Fevers and Leukocytosis in a Patient With Severe COVID-19 | Zendy

Arielle Sasson | Zendy; Amna Aijaz | Zendy; Svetlana Chernyavsky | Zendy; Nadim Salomon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Coronavirus Disease 2019 (COVID-19) Mystery: Persistent Fevers and Leukocytosis in a Patient With Severe COVID-19

Author(s) -

Arielle Sasson,

Amna Aijaz,

Svetlana Chernyavsky,

Nadim Salomon

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa558

Subject(s) - medicine , leukocytosis , covid-19 , tocilizumab , disease , coronavirus , pneumonia , lopinavir , pediatrics , infectious disease (medical specialty)

Short-course glucocorticosteroids are being used and tocilizumab (TCZ) had been used to treat patients with severe coronavirus disease 2019 (COVID-19) disease. These agents, when administered individually, have been associated with tuberculosis (TB) during chronic use. We report a case of TB in a 44-year-old male with diabetes and severe COVID-19 who received high-dose short-course glucocorticosteroids and a single dose of TCZ. The clinical presentation was atypical with unresolving fevers and leukocytosis, progressive lower lobe cavities, and hilar adenopathy. Delayed diagnosis led to prolonged hospitalization and extensive antibiotic use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research